Drug shortage: Lidocaine Hydrochloride Injection (LIDOCAINE, XYLOCAINE MPF, LIDOCAINE HYDROCHLORIDE)
FDA lists 67 presentations as Current. Availability: Unavailable (19), Limited Availability (1), Available (45). Reason: Demand increase for the drug; Other. Companies: Hospira, Inc., a Pfizer Company, Fresenius Kabi USA, LLC, Anthea Pharma, Eugia US LLC, Hikma Pharmaceuticals USA, Inc.….
- Published by source
- 2012-02-22
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-23
Affected
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Products
- Lidocaine Hydrochloride Injection LIDOCAINE XYLOCAINE MPF LIDOCAINE HYDROCHLORIDE XYLOCAINE LIDOCAINE HYDROCHLORIDE AND DEXTROSE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Next release October 2026. Check wholesalers for inventory.
- Estimated recovery: TBD
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2012-02-22
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #854 | new | 2026-10-22 | 537896663553…123101 | 1dcf95e9527d…3b22c6 |
| #1125 | update | 2026-10-23 | b5da91ce96a4…ef4fde | f8b109257340…011c61 |
| #1350 | update | 2026-10-23 | acc502c642e3…4b8a4b | 554c1e701320…7e79c4 |
Chain head: #1479 ad3417dbc128…777bd4